Literature DB >> 2594877

Concurrent validity of GHQ-28 and PSE as measures of change.

J Ormel1, M W Koeter, W van den Brink, R Giel.   

Abstract

Substantial cross-sectional correlations have been reported between the GHQ and PSE (and CIS) total scores. Although necessary, this is not a sufficient condition for assuming good validity of the GHQ as a severity measure in longitudinal and health care evaluation studies. For this purpose the GHQ should also accurately reflect changes in severity over time. To examine their concurrent validity, GHQ and PSE scores were compared, in a three-wave longitudinal study, among 175 new psychiatric out-patients. Using a longitudinal structural equation model that takes measurement error into account, the strength of both the cross-sectional and longitudinal relationship between GHQ and PSE were estimated. The GHQ performed remarkably well; changes in severity as defined by PSE-ID and PSE total score were clearly reflected by changes in GHQ scores. The revised scoring method of the GHQ proposed by Goodchild and Duncan-Jones did not yield superior results.

Entities:  

Mesh:

Year:  1989        PMID: 2594877     DOI: 10.1017/s0033291700005730

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  3 in total

1.  Measuring change with the General Health Questionnaire (GHQ). The problem of retest effects.

Authors:  J Ormel; M W Koeter; W van den Brink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-09       Impact factor: 4.328

2.  How general practice patients with emotional problems presenting with somatic or psychological symptoms explain their improvement.

Authors:  J Cape
Journal:  Br J Gen Pract       Date:  2001-09       Impact factor: 5.386

3.  Psychosocial and behavioral pre-treatment predictors of weight loss outcomes.

Authors:  S D Anton; C K Martin; L Redman; E York-Crowe; L K Heilbronn; H Han; D A Williamson; E Ravussin
Journal:  Eat Weight Disord       Date:  2008-03       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.